Behavioral and Psychiatric Symptoms of Dementia and Rate of Decline in Alzheimer’s Disease
Alzheimer's disease causes both cognitive and non-cognitive symptoms. There is increasing evidence that the presentation and course of Alzheimer's disease is highly heterogenous. This heterogeneity presents challenges to patients, their families, and clinicians due to the difficulty in pro...
Saved in:
| Published in | Frontiers in pharmacology Vol. 10; p. 1062 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
Frontiers Media S.A
24.09.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Alzheimer's disease causes both cognitive and non-cognitive symptoms. There is increasing evidence that the presentation and course of Alzheimer's disease is highly heterogenous. This heterogeneity presents challenges to patients, their families, and clinicians due to the difficulty in prognosticating future symptoms and functional impairment. Behavioral and psychiatric symptoms are emerging as a significant contributor to this clinical heterogeneity. These symptoms have been linked to multiple areas of neurodegeneration, which may suggest that they are representative of network-wide dysfunction in the brain. However, current diagnostic criteria for Alzheimer's disease focus exclusively on the cognitive aspects of disease. Behavioral and psychiatric symptoms have been found in multiple studies to be related to disease severity and to contribute to disease progression over time. A better understanding of how behavioral and psychiatric symptoms relate to cognitive aspects of Alzheimer's disease would help to refine the models of disease and hopefully lead to improved ability to develop therapeutic options for this devastating disease. |
|---|---|
| AbstractList | Alzheimer's disease causes both cognitive and non-cognitive symptoms. There is increasing evidence that the presentation and course of Alzheimer's disease is highly heterogenous. This heterogeneity presents challenges to patients, their families, and clinicians due to the difficulty in prognosticating future symptoms and functional impairment. Behavioral and psychiatric symptoms are emerging as a significant contributor to this clinical heterogeneity. These symptoms have been linked to multiple areas of neurodegeneration, which may suggest that they are representative of network-wide dysfunction in the brain. However, current diagnostic criteria for Alzheimer's disease focus exclusively on the cognitive aspects of disease. Behavioral and psychiatric symptoms have been found in multiple studies to be related to disease severity and to contribute to disease progression over time. A better understanding of how behavioral and psychiatric symptoms relate to cognitive aspects of Alzheimer's disease would help to refine the models of disease and hopefully lead to improved ability to develop therapeutic options for this devastating disease.Alzheimer's disease causes both cognitive and non-cognitive symptoms. There is increasing evidence that the presentation and course of Alzheimer's disease is highly heterogenous. This heterogeneity presents challenges to patients, their families, and clinicians due to the difficulty in prognosticating future symptoms and functional impairment. Behavioral and psychiatric symptoms are emerging as a significant contributor to this clinical heterogeneity. These symptoms have been linked to multiple areas of neurodegeneration, which may suggest that they are representative of network-wide dysfunction in the brain. However, current diagnostic criteria for Alzheimer's disease focus exclusively on the cognitive aspects of disease. Behavioral and psychiatric symptoms have been found in multiple studies to be related to disease severity and to contribute to disease progression over time. A better understanding of how behavioral and psychiatric symptoms relate to cognitive aspects of Alzheimer's disease would help to refine the models of disease and hopefully lead to improved ability to develop therapeutic options for this devastating disease. Alzheimer’s disease causes both cognitive and non-cognitive symptoms. There is increasing evidence that the presentation and course of Alzheimer’s disease is highly heterogenous. This heterogeneity presents challenges to patients, their families, and clinicians due to the difficulty in prognosticating future symptoms and functional impairment. Behavioral and psychiatric symptoms are emerging as a significant contributor to this clinical heterogeneity. These symptoms have been linked to multiple areas of neurodegeneration, which may suggest that they are representative of network-wide dysfunction in the brain. However, current diagnostic criteria for Alzheimer’s disease focus exclusively on the cognitive aspects of disease. Behavioral and psychiatric symptoms have been found in multiple studies to be related to disease severity and to contribute to disease progression over time. A better understanding of how behavioral and psychiatric symptoms relate to cognitive aspects of Alzheimer’s disease would help to refine the models of disease and hopefully lead to improved ability to develop therapeutic options for this devastating disease. |
| Author | Stern, Yaakov Gottesman, Reena T. |
| AuthorAffiliation | 2 Division of Cognitive Neuroscience, Department of Neurology, Columbia University Medical Center , New York, NY , United States 1 Division of Aging and Dementia, Department of Neurology, Columbia University Medical Center , New York, NY , United States |
| AuthorAffiliation_xml | – name: 1 Division of Aging and Dementia, Department of Neurology, Columbia University Medical Center , New York, NY , United States – name: 2 Division of Cognitive Neuroscience, Department of Neurology, Columbia University Medical Center , New York, NY , United States |
| Author_xml | – sequence: 1 givenname: Reena T. surname: Gottesman fullname: Gottesman, Reena T. – sequence: 2 givenname: Yaakov surname: Stern fullname: Stern, Yaakov |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31616296$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kstu1DAUhi1UREvpnhXKks0MviS-bJBKW6BSJRCXHZJ14px0XCXxYHsqDSteo6_XJ8Ez06IWCW9sHf_n-335n5O9KUxIyEtG50Jo86ZfLiDOOWVmThmV_Ak5YFKKmdGM7z1Y75OjlK5oGcIYIetnZF8wySQ38oD8eIcLuPYhwlDB1FWf09otPOToXfV1PS5zGFMV-uoUR5yyh63oC2TcFd3gJ6z8VB0PvxboR4y3v29SdeoTQsIX5GkPQ8Kju_mQfH9_9u3k4-zi04fzk-OLmWu4zjNQyHQtOiU5Vb1rjeOCNuWMddty3fVNQ7GroXMIANiYpuWqdVj32lDaqlockvMdtwtwZZfRjxDXNoC320KIlxZi9m5Aq5SjimvK6q6tXU-1MYBoWqFMZ5CKwnq7Yy1X7YjFc8rlbR5BH-9MfmEvw7WVSmpTswJ4fQeI4ecKU7ajTw6HASYMq2TL3STnXGtdpK8eev01uf-eIpA7gYshpYi9dT5D9mFj7QfLqN1EwW6jYDdRsNsolEb6T-M9-78tfwBVXrkF |
| CitedBy_id | crossref_primary_10_3389_frdem_2023_1226060 crossref_primary_10_1002_mdc3_13684 crossref_primary_10_1002_gps_5460 crossref_primary_10_3390_brainsci13081139 crossref_primary_10_1038_s41598_022_18470_8 crossref_primary_10_2174_1874467214666210309115605 crossref_primary_10_7717_peerj_18026 crossref_primary_10_1097_MED_0000000000000564 crossref_primary_10_3390_ijerph17061913 crossref_primary_10_1002_gps_5813 crossref_primary_10_3390_brainsci12121636 crossref_primary_10_3390_geriatrics7010014 crossref_primary_10_1155_2021_3961445 crossref_primary_10_1007_s11011_021_00679_7 crossref_primary_10_12688_f1000research_26022_2 crossref_primary_10_1016_j_gerinurse_2021_10_016 crossref_primary_10_1159_000516340 crossref_primary_10_3390_ph17020237 crossref_primary_10_1016_j_ijans_2023_100601 crossref_primary_10_1186_s12888_020_02537_9 crossref_primary_10_1159_000519534 crossref_primary_10_3233_ADR_210067 crossref_primary_10_2174_0118715273275957231102044934 crossref_primary_10_1007_s00702_021_02449_2 crossref_primary_10_7759_cureus_64152 crossref_primary_10_20344_amp_18763 crossref_primary_10_1159_000540689 crossref_primary_10_1007_s40120_023_00472_x crossref_primary_10_1016_j_ijnurstu_2022_104181 crossref_primary_10_3390_healthcare11060868 crossref_primary_10_1002_gps_5568 crossref_primary_10_1002_alz_12509 crossref_primary_10_1016_j_exger_2023_112197 crossref_primary_10_3390_pharmaceutics17010128 crossref_primary_10_1016_j_ijnurstu_2021_104012 crossref_primary_10_2174_0115672050309014240705113444 crossref_primary_10_1177_07334648221079118 crossref_primary_10_1186_s12888_024_05697_0 crossref_primary_10_2174_1871527320666210126114442 crossref_primary_10_1891_JNM_D_21_00028 crossref_primary_10_14283_jfa_2020_36 crossref_primary_10_1086_JCE2020312099 crossref_primary_10_3389_fneur_2022_1065335 crossref_primary_10_2174_1567205020666230908163414 crossref_primary_10_3390_geriatrics10010020 crossref_primary_10_1016_j_neuropsychologia_2024_109006 crossref_primary_10_3390_genes14112048 crossref_primary_10_1080_07317115_2022_2162468 crossref_primary_10_3233_JAD_201427 crossref_primary_10_1093_braincomms_fcab026 |
| Cites_doi | 10.1002/gps.490 10.1212/01.WNL.0000138440.39918.0C 10.1001/archneur.1992.00530280051022 10.1111/j.1750-3639.2000.tb00269.x 10.1017/S1041610215002069 10.1002/gps.1594 10.1016/j.jalz.2011.03.005 10.1212/WNL.0000000000004058 10.1016/j.jalz.2012.07.003 10.3233/JAD-2010-101212 10.1016/j.neuropsychologia.2004.06.007 10.1212/WNL.56.9.1154 10.1097/YCO.0000000000000309 10.4088/JCP.v69n0602 10.1001/archneur.62.10.1601 10.1007/s10072-007-0794-0 10.1371/journal.pone.0114774 10.1001/jama.288.12.1475 10.1017/S1041610212001202 10.1093/brain/awn151 10.3233/JAD-160767 10.1159/000090251 10.3233/JAD-131142 10.1002/gps.930080906 10.1111/j.1600-0447.1993.tb03394.x 10.1176/jnp.12.1.25 10.1016/j.jagp.2013.01.051 10.1046/j.1365-2389.2003.51308.x 10.1002/(SICI)1099-1166(200002)15:2<99::AID-GPS82>3.0.CO;2-5 10.3233/JAD-160780 10.1159/000066508 10.1016/S0197-4580(97)00057-2 10.1016/j.cbi.2012.09.016 10.1002/gps.4291 10.2174/1567205014666170829114346 10.1176/jnp.7.4.476 10.1016/j.jalz.2015.05.017 10.1212/WNL.35.4.453 10.1097/00002093-199307010-00002 10.3233/JAD-180688 10.1016/j.bbr.2010.07.016 10.1002/gps.5030 10.2147/NDT.S38942 10.1002/gps.4037 10.1177/1533317513507373 10.1016/j.jagp.2013.03.006 10.1101/cshperspect.a033118 10.3233/JAD-2010-101215 10.3233/JAD-170697 10.3233/JAD-140309 10.1159/000342119 10.1002/gps.781 10.1136/jnnp.69.2.172 10.1001/jamaneurol.2015.0606 10.1111/j.1532-5415.1986.tb04303.x 10.3389/fnagi.2017.00182 10.1097/PSY.0b013e3181a651b3 10.3233/JAD-170914 10.1016/j.jagp.2017.10.011 10.1097/00002093-199911002-00002 10.1001/jama.287.16.2090 10.1212/01.WNL.0000036904.73393.E4 10.1001/archneur.56.10.1266 10.1159/000487938 10.1097/00019442-200301000-00011 10.1080/13607860701368463 10.1007/s00401-011-0821-3 10.1176/appi.neuropsych.16080155 10.1002/hbm.22248 10.1002/gps.4911 10.1016/j.jagp.2013.03.014 10.1016/S0140-6736(96)10203-8 10.1016/j.trci.2019.01.002 10.1016/j.neurobiolaging.2018.03.013 10.3233/JAD-150944 10.1176/jnp.13.1.50 10.1159/000067972 10.1176/appi.ajp.2014.14040480 10.1002/ana.72 10.1016/j.jalz.2012.09.015. 10.1176/ajp.149.2.184 10.1177/0091270011405497 |
| ContentType | Journal Article |
| Copyright | Copyright © 2019 Gottesman and Stern. Copyright © 2019 Gottesman and Stern 2019 Gottesman and Stern |
| Copyright_xml | – notice: Copyright © 2019 Gottesman and Stern. – notice: Copyright © 2019 Gottesman and Stern 2019 Gottesman and Stern |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.3389/fphar.2019.01062 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1663-9812 |
| ExternalDocumentID | oai_doaj_org_article_77c0728014db4cf0899aee9b379d9e03 PMC6768941 31616296 10_3389_fphar_2019_01062 |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: NIA NIH HHS grantid: R01 AG007370 |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM IPNFZ NPM RIG 7X8 5PM |
| ID | FETCH-LOGICAL-c528t-a7e1843d76207fcb9c23053164bb28df550ed4adceaaae595b27bce4f8900b743 |
| IEDL.DBID | M48 |
| ISSN | 1663-9812 |
| IngestDate | Tue Aug 26 23:51:07 EDT 2025 Thu Aug 21 13:37:51 EDT 2025 Fri Jul 11 07:28:40 EDT 2025 Thu Apr 03 06:53:33 EDT 2025 Tue Jul 01 03:27:24 EDT 2025 Thu Apr 24 23:04:14 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | functional decline Alzheimer’s disease cognitive decline behavioral and psychiatric symptoms predictors of decline |
| Language | English |
| License | Copyright © 2019 Gottesman and Stern. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c528t-a7e1843d76207fcb9c23053164bb28df550ed4adceaaae595b27bce4f8900b743 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Reviewed by: Kurt A. Jellinger, University of Vienna, Austria; Lucio Tremolizzo, University of Milano-Bicocca, Italy This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology Edited by: Lydia Gimenez-Llort, Autonomous University of Barcelona, Spain |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2019.01062 |
| PMID | 31616296 |
| PQID | 2306222888 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_77c0728014db4cf0899aee9b379d9e03 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6768941 proquest_miscellaneous_2306222888 pubmed_primary_31616296 crossref_citationtrail_10_3389_fphar_2019_01062 crossref_primary_10_3389_fphar_2019_01062 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-09-24 |
| PublicationDateYYYYMMDD | 2019-09-24 |
| PublicationDate_xml | – month: 09 year: 2019 text: 2019-09-24 day: 24 |
| PublicationDecade | 2010 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in pharmacology |
| PublicationTitleAlternate | Front Pharmacol |
| PublicationYear | 2019 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Garcia-Alloza (B26) 2005; 43 Trzepacz (B73) 2013 Chan (B10) 2003; 18 Nakaaki (B49) 2013; 9 Roudil (B58) 2018; 63 Halpern (B31) 2019; 34 Hamilton (B32) 2000; 10 Maurer (B44) 1997; 349 Pepeu (B51) 2013; 203 Sinforiani (B65) 2007; 28 Ossenkoppele (B50) 2013; 9 Doody (B20) 2001; 56 Leroi (B40) 2003; 11 Sultzer (B69) 1995; 7 Wilson (B80) 2006; 26 Zhu (B84) 2013; 9 Holroyd (B35) 2000; 12 Bruen (B8) 2008; 131 Qian (B54) 2018; 15 Lyketsos (B43) 2002; 288 Garre-Olmo (B28) 2010; 22 Mayeux (B45) 1985; 35 Sambrook (B34) 2006; 21 Aalten (B1) 2003; 15 Costa (B14) 2018; 19 Rattinger (B56) 2019; 5 Donovan (B19) 2014; 22 Razlighi (B57) 2014; 38 Samtani (B60) 2012; 52 Haupt (B33) 1993; 8 Poulin (B53) 2017; 60 van der Linde (B75) 2014; 29 Cohen-Mansfield (B12) 1986; 34 McKhann (B47) 2011; 7 Balthazar (B3) 2014; 35 D’Onofrio (B15) 2016; 51 Victoroff (B77) 2018; 30 Stella (B67) 2016; 28 Vermeiren (B76) 2014; 41 Lopez (B41) 2001; 13 Sennik (B64) 2017; 55 Vilalta-Franch (B78) 2013; 21 Wilson (B81) 2000; 69 Bertrand (B6) 2017; 9 Lemstra (B39) 2003; 49 Scarmeas (B61) 2004; 63 Zahodne (B83) 2015; 23 Devanand (B18) 1992; 49 McKeith (B46) 2017; 89 Connors (B13) 2018; 26 Holtzer (B36) 2003; 51 Forlenza (B24) 2017; 30 Lopez (B42) 1999; 56 Stern (B68) 1993; 7 Sonnenberg (B66) 2013; 25 Forstl (B25) 1993; 87 Tekin (B71) 2001; 49 Wadsworth (B79) 2012; 34 Yaffe (B82) 2002; 287 Van Den Wijngaart (B74) 2007; 11 Chung (B11) 2015; 72 Hallikainen (B30) 2018; 33 Tchalla (B70) 2018; 45 Casanova (B9) 2011; 122 (B72) 1997; 18 Alexander (B2) 2011; 216 Rafii (B55) 2014; 29 Barnes (B4) 2009; 71 Bassiony (B5) 2000; 15 Blanc (B7) 2014; 9 Peters (B52) 2015; 172 Ehrenberg (B21) 2018; 66 Jeste (B38) 1992; 149 Scarmeas (B62) 2005; 62 Garre-Olmo (B27) 2010; 22 Salzman (B59) 2008; 69 Devanand (B17) 1999; 13 Schnaider Beeri (B63) 2002; 17 Hallikainen (B29) 2018; 61 Dauwan (B16) 2018; 67 Ismail (B37) 2016; 12 Murman (B48) 2002; 59 Erkkinen (B22) 2018; 10 Fischer (B23) 2016; 31 |
| References_xml | – volume: 17 start-page: 403 year: 2002 ident: B63 article-title: The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer’s disease patients publication-title: Int. J. Geriatr. Psychiatry doi: 10.1002/gps.490 – volume: 63 start-page: 975 year: 2004 ident: B61 article-title: Motor signs during the course of Alzheimer disease publication-title: Neurology. doi: 10.1212/01.WNL.0000138440.39918.0C – volume: 49 start-page: 371 year: 1992 ident: B18 article-title: The columbia university scale for psychopathology in Alzheimer’s disease publication-title: Arch Neurol. doi: 10.1001/archneur.1992.00530280051022 – volume: 10 start-page: 378 year: 2000 ident: B32 article-title: Lewy Bodies in Alzheimer’s disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry publication-title: Brain Pathol. doi: 10.1111/j.1750-3639.2000.tb00269.x – volume: 28 start-page: 779 year: 2016 ident: B67 article-title: Association of neuropsychiatric syndromes with global clinical deterioration in Alzheimer’s disease patients publication-title: Int. Psychogeriatr. doi: 10.1017/S1041610215002069 – volume: 21 start-page: 972 year: 2006 ident: B34 article-title: The contribution of neuropsychiatric symptoms to the cost of dementia care publication-title: Int. J. Geriatr. Psychiatry doi: 10.1002/gps.1594 – volume: 7 start-page: 263 year: 2011 ident: B47 article-title: The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease publication-title: J. Alzheimers Assoc. doi: 10.1016/j.jalz.2011.03.005 – volume: 89 start-page: 88 year: 2017 ident: B46 article-title: Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium publication-title: Neurology. doi: 10.1212/WNL.0000000000004058 – volume: 9 start-page: 414 year: 2013 ident: B50 article-title: Impact of molecular imaging on the diagnostic process in a memory clinic publication-title: Alzheimers Dement. doi: 10.1016/j.jalz.2012.07.003 – volume: 22 start-page: 1157 year: 2010 ident: B28 article-title: Grouping and trajectories of the neuropsychiatric symptoms in patients with Alzheimer’s disease, Part I: symptom clusters publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-2010-101212 – volume: 43 start-page: 442 year: 2005 ident: B26 article-title: Cholinergic–serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer’s disease publication-title: Neuropsychologia. doi: 10.1016/j.neuropsychologia.2004.06.007 – volume: 56 start-page: 1154 year: 2001 ident: B20 article-title: Practice parameter: management of dementia (an evidence-based review) publication-title: Neurology. doi: 10.1212/WNL.56.9.1154 – volume: 30 start-page: 151 year: 2017 ident: B24 article-title: Recent advances in the management of neuropsychiatric symptoms in dementia publication-title: Curr. Opin. Psychiatry doi: 10.1097/YCO.0000000000000309 – volume: 69 start-page: 889 year: 2008 ident: B59 article-title: Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy publication-title: J. Clin. Psychiatry doi: 10.4088/JCP.v69n0602 – volume: 62 start-page: 1601 year: 2005 ident: B62 article-title: Delusions and hallucinations are associated with worse outcome in alzheimer disease publication-title: Arch Neurol. doi: 10.1001/archneur.62.10.1601 – volume: 28 start-page: 96 year: 2007 ident: B65 article-title: Hallucinations and sleep–wake cycle in Alzheimer’s disease: a questionnaire-based study in 218 patients publication-title: Neurol. Sci. doi: 10.1007/s10072-007-0794-0 – volume: 9 year: 2014 ident: B7 article-title: Right anterior insula: core region of hallucinations in cognitive neurodegenerative diseases publication-title: PLoS One doi: 10.1371/journal.pone.0114774 – volume: 288 start-page: 1475 year: 2002 ident: B43 article-title: Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study publication-title: JAMA. doi: 10.1001/jama.288.12.1475 – volume: 25 start-page: 61 year: 2013 ident: B66 article-title: Gender differences in the relation between depression and social support in later life publication-title: Int. Psychogeriatr. doi: 10.1017/S1041610212001202 – volume: 131 start-page: 2455 year: 2008 ident: B8 article-title: Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease publication-title: Brain doi: 10.1093/brain/awn151 – volume: 60 start-page: 483 year: 2017 ident: B53 article-title: Risk factors, neuroanatomical correlates, and outcome of neuropsychiatric symptoms in Alzheimer’s disease publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-160767 – volume: 26 start-page: 68 year: 2006 ident: B80 article-title: Hallucinations, cognitive decline, and death in Alzheimer’s disease publication-title: Neuroepidemiology doi: 10.1159/000090251 – volume: 38 start-page: 661 year: 2014 ident: B57 article-title: A new algorithm for predicting time to disease endpoints in Alzheimer’s disease patients publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-131142 – volume: 8 start-page: 741 year: 1993 ident: B33 article-title: Predictors of nursing home placement in patients with Alzheimer’s disease publication-title: Int. J. Geriatr. Psychiatry doi: 10.1002/gps.930080906 – volume: 19 start-page: 10 year: 2018 ident: B14 article-title: Costs of care of agitation associated with dementia in 8 European countries: results from the right time place care study publication-title: JAMDA – volume: 87 start-page: 395 year: 1993 ident: B25 article-title: Psychotic features and the course of Alzheimer’s disease: relationship to cognitive, electroencephalographic and computerized tomography findings publication-title: Acta Psychiatr. Scan. doi: 10.1111/j.1600-0447.1993.tb03394.x – volume: 12 start-page: 25 year: 2000 ident: B35 article-title: Occipital atrophy is associated with visual hallucinations in Alzheimer’s disease publication-title: J. Neuropsychiatr Clin. Neurosci. doi: 10.1176/jnp.12.1.25 – volume: 21 start-page: 1135 year: 2013 ident: B78 article-title: Psychosis of Alzheimer disease: prevalence, incidence, persistence, risk factors, and mortality publication-title: Am. J. Geriatr. Psychiatry doi: 10.1016/j.jagp.2013.01.051 – volume: 51 start-page: 953 year: 2003 ident: B36 article-title: Psychopathological features in Alzheimer’s disease: course and relationship with cognitive status publication-title: J. Am. Geriatr. Soc. doi: 10.1046/j.1365-2389.2003.51308.x – volume: 15 start-page: 99 year: 2000 ident: B5 article-title: Delusions and hallucinations in Alzheimer’s disease: prevalence and clinical correlates publication-title: Int. J. Geriatr. Psychiatry doi: 10.1002/(SICI)1099-1166(200002)15:2<99::AID-GPS82>3.0.CO;2-5 – volume: 55 start-page: 1519 year: 2017 ident: B64 article-title: Risk factors and pathological substrates associated with agitation/aggression in Alzheimer’s disease: a preliminary study using NACC data publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-160780 – volume: 49 start-page: 55 year: 2003 ident: B39 article-title: The cholinergic deficiency syndrome and its therapeutic implications publication-title: Gerontology. doi: 10.1159/000066508 – volume: 18 start-page: S1 year: 1997 ident: B72 article-title: Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s disease publication-title: Neurobiol. Aging doi: 10.1016/S0197-4580(97)00057-2 – volume: 203 start-page: 361 year: 2013 ident: B51 article-title: Effect of cholinesterase inhibitors on attention publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2012.09.016 – volume: 31 start-page: 76 year: 2016 ident: B23 article-title: Gray matter atrophy in patients with mild cognitive impairment/Alzheimer’s disease over the course of developing delusions publication-title: Int. J. Geriatr. Psychiatry doi: 10.1002/gps.4291 – volume: 15 start-page: 187 year: 2018 ident: B54 article-title: Association between psychosis phenotype and APOE genotype on the clinical profiles of Alzheimer’s disease publication-title: Curr. Alzheimer Res. doi: 10.2174/1567205014666170829114346 – volume: 7 start-page: 476 year: 1995 ident: B69 article-title: The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer’s disease publication-title: J. Neuropsychiatr Clin. Neurosci. doi: 10.1176/jnp.7.4.476 – volume: 12 start-page: 195 year: 2016 ident: B37 article-title: Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment publication-title: Alzheimers Dement. doi: 10.1016/j.jalz.2015.05.017 – volume: 35 start-page: 453 year: 1985 ident: B45 article-title: Heterogeneity in dementia of the Alzheimer Type; evidence of subgroups publication-title: Neurology. doi: 10.1212/WNL.35.4.453 – volume: 7 start-page: 3 year: 1993 ident: B68 article-title: Multicenter study of predictors of disease course in Alzheimer disease (the “predictors study”) publication-title: Alzheimer Dis. Assoc. Disord. doi: 10.1097/00002093-199307010-00002 – volume: 66 start-page: 115 year: 2018 ident: B21 article-title: Neuropathologic correlates of psychiatric symptoms in Alzheimer’s disease publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-180688 – volume: 216 start-page: 77 year: 2011 ident: B2 article-title: Increased aggression in males in transgenic Tg2576 mouse model of Alzheimer’s disease publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2010.07.016 – volume: 34 start-page: 420 year: 2019 ident: B31 article-title: Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia publication-title: Int. J. Geriatr. Psychiatry doi: 10.1002/gps.5030 – volume: 9 start-page: 25 year: 2013 ident: B49 article-title: Decreased white matter integrity before the onset of delusions in patients with Alzheimer’s disease: diffusion tensor imaging publication-title: Neuropsychiatr. Dis. Treat doi: 10.2147/NDT.S38942 – volume: 29 start-page: 562 year: 2014 ident: B75 article-title: Grouping of behavioural and psychological symptoms of dementia publication-title: Int. J. Geriatr. Psychiatry doi: 10.1002/gps.4037 – volume: 29 start-page: 159 year: 2014 ident: B55 article-title: Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer’s disease publication-title: Am. J. Alzheimers Dis. Other Demen. doi: 10.1177/1533317513507373 – volume: 22 start-page: 1168 year: 2014 ident: B19 article-title: Regional cortical thinning predicts worsening apathy and halluciantions across the Alzheimer Disease Spectrum publication-title: Am. J. Geriatr. Psychiatry. doi: 10.1016/j.jagp.2013.03.006 – volume: 10 start-page: 1 year: 2018 ident: B22 article-title: Clinical neurology and epidemiology of major neurodegenerative diseases publication-title: Cold Spring Harb. Perspect. Biol. doi: 10.1101/cshperspect.a033118 – volume: 22 start-page: 1169 year: 2010 ident: B27 article-title: Grouping and trajectories of neuropsychiatric symptoms in patients with Alzheimer’s disease publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-2010-101215 – volume: 61 start-page: 1367 year: 2018 ident: B29 article-title: The progression of neuropsychiatric symptoms in Alzheimer’s disease during a five-year follow-up: Kuopio ALSOVA Study publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-170697 – volume: 41 start-page: 819 year: 2014 ident: B76 article-title: Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer’s disease publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-140309 – volume: 34 start-page: 96 year: 2012 ident: B79 article-title: Neuropsychiatric Symptoms and Global Functional Impairment along the Alzheimer’s continuum publication-title: Dement. Geriatr. Cogn. Disord. doi: 10.1159/000342119 – volume: 18 start-page: 174 year: 2003 ident: B10 article-title: Prevalence and correlates of behavioral and psychiatric symptoms in community-dwelling elders with dementia or mild cognitive impairment: the Memory and Medical Care Study publication-title: Int. J. Geriatr. Psychiatry doi: 10.1002/gps.781 – volume: 69 start-page: 172 year: 2000 ident: B81 article-title: Hallucinations, delusions, and cognitive decline in Alzheimer’s disease publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp.69.2.172 – volume: 72 start-page: 789 year: 2015 ident: B11 article-title: Clinical features of Alzheimer disease with and without Lewy bodies publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2015.0606 – volume: 34 start-page: 722 year: 1986 ident: B12 article-title: Agitated behaviors in the elderly publication-title: J. Am. Geriatr. Soc. doi: 10.1111/j.1532-5415.1986.tb04303.x – volume: 9 start-page: 1 year: 2017 ident: B6 article-title: Behavioral and psychological symptoms impact clinical competence in Alzheimer’s disease publication-title: Front. Aging Neurosci doi: 10.3389/fnagi.2017.00182 – volume: 71 start-page: 652 year: 2009 ident: B4 article-title: Hostility and change in cognitive function over time in older blacks and whites publication-title: Psychosom. Med. doi: 10.1097/PSY.0b013e3181a651b3 – volume: 63 start-page: 1317 year: 2018 ident: B58 article-title: Influence of Lewy pathology on Alzheimer’s disease phenotype: a retrospective clinico-pathological study publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-170914 – volume: 26 start-page: 304 year: 2018 ident: B13 article-title: Psychosis and clinical outcomes in Alzheimer disease: a longitudinal study publication-title: Am. J. Geriatr. Psychiatry doi: 10.1016/j.jagp.2017.10.011 – volume: 13 start-page: 8 year: 1999 ident: B17 article-title: The interrelations between psychosis, behavioral disturbances, and depression in Alzheimer disease publication-title: Alzheimer Dis. Assoc. Disord. doi: 10.1097/00002093-199911002-00002 – volume: 287 start-page: 2090 year: 2002 ident: B82 article-title: Patient and caregiver characteristics and nursing home placement in patients with dementia publication-title: JAMA. doi: 10.1001/jama.287.16.2090 – volume: 59 start-page: 1721 year: 2002 ident: B48 article-title: The incremental direct costs associated with behavioral symptoms in AD publication-title: Neurology. doi: 10.1212/01.WNL.0000036904.73393.E4 – volume: 56 start-page: 1266 year: 1999 ident: B42 article-title: Psychiatric medication and abnormal behavior as predictors of progression in probable alzheimer disease publication-title: Arch Neurol. doi: 10.1001/archneur.56.10.1266 – volume: 45 start-page: 56 year: 2018 ident: B70 article-title: Predictors of rapid cognitive decline in patients with mild-to-moderate Alzheimer disease: a prospective cohort study with 12-month follow up performed in memory clinics publication-title: Dement. Geriatr. Cogn. Disord. doi: 10.1159/000487938 – volume: 11 start-page: 83 year: 2003 ident: B40 article-title: The epidemiology of psychosis in dementia publication-title: Am. J. Geriatr. Psychiatry doi: 10.1097/00019442-200301000-00011 – volume: 11 start-page: 626 year: 2007 ident: B74 article-title: The influence of stressors, appraisal and personal conditions on the burden of spousal caregivers of persons with dementia publication-title: Aging Ment. Health doi: 10.1080/13607860701368463 – volume: 122 start-page: 117 year: 2011 ident: B9 article-title: Clinicopathological correlates of behavioral and psychological symptoms of dementia publication-title: Acta. Neuropathol. doi: 10.1007/s00401-011-0821-3 – volume: 30 start-page: 14 year: 2018 ident: B77 article-title: Noncognitive behavioral changes associated with Alzheimer’s disease: implications of neuroimaging findings publication-title: J. Neuropsychiatry Clin. Neurosci. doi: 10.1176/appi.neuropsych.16080155 – volume: 35 start-page: 1237 year: 2014 ident: B3 article-title: Neuropsychiatric symptoms in Alzheimer’s disease are related to functional connectivity alterations in the salience network publication-title: Hum. Brain Mapp. doi: 10.1002/hbm.22248 – volume: 33 start-page: 1207 year: 2018 ident: B30 article-title: The influence of the individual neuropsychiatric symptoms of people with Alzheimer disease on family caregiver distress—a longitudinal ALSOVA study publication-title: Int. J. Geriatr. Psychiatry doi: 10.1002/gps.4911 – volume: 23 start-page: 130 year: 2015 ident: B83 article-title: Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, and agitation/aggression publication-title: Am. J. Geriatr. Psychiatry doi: 10.1016/j.jagp.2013.03.014 – volume: 349 start-page: 1546 year: 1997 ident: B44 article-title: Auguste D and Alzheimer’s disease publication-title: Lancet. doi: 10.1016/S0140-6736(96)10203-8 – volume: 5 start-page: 81 year: 2019 ident: B56 article-title: Neuropsychiatric symptoms in patients with dementia and the longitudinal costs of informal care in the Cache County population publication-title: Alzheimers Dement. doi: 10.1016/j.trci.2019.01.002 – volume: 67 start-page: 75 year: 2018 ident: B16 article-title: EEG-based neurophysiological indicators of hallucinations in Alzheimer’s disease: comparison with dementia with Lewy bodies publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2018.03.013 – volume: 51 start-page: 427 year: 2016 ident: B15 article-title: Delusions in patients with Alzheimer’s disease: a multidimensional approach publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-150944 – start-page: 1 volume-title: Alzheimers Dement. year: 2013 ident: B73 article-title: Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer’s disease – volume: 13 start-page: 50 year: 2001 ident: B41 article-title: The psychotic phenomenon in probable Alzheimer’s disease publication-title: J. Neuropsychiatr Clin. Neurosci. doi: 10.1176/jnp.13.1.50 – volume: 15 start-page: 99 year: 2003 ident: B1 article-title: Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory publication-title: Dement. Geriatr. Cogn. Disord. doi: 10.1159/000067972 – volume: 172 start-page: 460 year: 2015 ident: B52 article-title: Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death publication-title: Cache County Demen. Progression Stud. doi: 10.1176/appi.ajp.2014.14040480 – volume: 49 start-page: 355 year: 2001 ident: B71 article-title: Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden in associated with agitation in Alzheimer disease publication-title: Ann. Neurol. doi: 10.1002/ana.72 – volume: 9 start-page: 733 year: 2013 ident: B84 article-title: Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer’s disease publication-title: Alzheimers Dement. doi: 10.1016/j.jalz.2012.09.015. – volume: 149 start-page: 184 year: 1992 ident: B38 article-title: Cognitive deficits of patients with Alzheimer’s disease with and without delusions publication-title: Am. J. Psychiatry. doi: 10.1176/ajp.149.2.184 – volume: 52 start-page: 629 year: 2012 ident: B60 article-title: An improved model for disease progression in patients from the Alzheimer’s disease neuroimaging initiative publication-title: J. Clin. Pharmacol. doi: 10.1177/0091270011405497 |
| SSID | ssj0000399364 |
| Score | 2.4337265 |
| SecondaryResourceType | review_article |
| Snippet | Alzheimer's disease causes both cognitive and non-cognitive symptoms. There is increasing evidence that the presentation and course of Alzheimer's disease is... Alzheimer’s disease causes both cognitive and non-cognitive symptoms. There is increasing evidence that the presentation and course of Alzheimer’s disease is... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1062 |
| SubjectTerms | Alzheimer’s disease behavioral and psychiatric symptoms cognitive decline functional decline Pharmacology predictors of decline |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NahsxEBYlp1xKm_Rn2yaoEAKFbL27lqXV0c4PIdBi2gRyKAhJK-GFeG1i5-Cc8hp5vTxJZiTbsUtoL7lqtax2ZiTNp9F8Q8ie82AVQqPnpm3K2k6kknmZCu6tN21u2haTk3_85KcX7Oyyc7lS6gvvhEV64Ci4lhA2wxJKOasMsx6jVNo5adpCVtJFnk_Y81bAVFiDcd_lLMYlAYXJlh8PNPJ_5vI7wqBibR8KdP3P-Zh_X5Vc2XtO3pDXc6eRduNg35JXrtki-_3IOj07oOdPSVSTA7pP-0981LNt8qe3TMWnuqlof3HBubb092w4no6GEzry9CicFNY6dPoFPmhsxNxJR-uGdq9uB64euuuHu_sJPYqRnXfk4uT4_PA0nRdVSG2nKKepFg5LvFSwCGbCWyMtgBCYiJwZU5SVB8TiKqbhh7XWriM7phDGOuZLmWUG_I33ZKMZNe4jodZbhI94FAUgz-SGa-NBu-BRCpnxLCGthYiVnTOOY-GLKwXIA5WiglIUKkUFpSTk2_KNcWTb-EffHmpt2Q95skMDWI-aW4_6n_Uk5OtC5wrmFQZLdONGNxOF0AxPx8oyIR-iDSw_BdLKeSF5QsSadayNZf1JUw8CdzcHeCdZ_uklBv-ZbKI40hAj-0I2ptc3bgdcpKnZDbPhERa7EcE priority: 102 providerName: Directory of Open Access Journals |
| Title | Behavioral and Psychiatric Symptoms of Dementia and Rate of Decline in Alzheimer’s Disease |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31616296 https://www.proquest.com/docview/2306222888 https://pubmed.ncbi.nlm.nih.gov/PMC6768941 https://doaj.org/article/77c0728014db4cf0899aee9b379d9e03 |
| Volume | 10 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9swEBejg9GXse6vt65oMAqDunViRbIexmjXlTLoCFsDfRgISZYaQ2JncQrLnvY19vX2SXYnO0kzwh72akvY1t3pfj-d746Q186DVgiNyE3bmKVOxJJ5GQvurTcpN6nF5OSLT_x8wD5e9a5W6dHtAtYbqR32kxpMR4ffv83fgcG_RcYJ_vbIT4YaS3t25CEyHNiQ74JfEmimFy3YD_sy-mLOmljlxonb5F4KCIh3sYT_LTcVqvlvgqB__0l5yzWdPSD3W0xJjxsl2CF3XPmQ7PebotTzA3q5yrGqD-g-7a_KVc8fka8ny0x9qsuc9hf_PxeWfpmPJ7NqXNPK09NwkFjoMOgzQNTmIqZWOlqU9Hj0Y-iKsZv-_vmrpqdN4OcxGZx9uHx_Hrc9F2Lb62azWAuHHWBy2CMT4a2RFjgK2ClnxnSz3AOhcTnT8MFaa9eTPdMVxjrmM5kkBuDIE7JVVqV7Rqj1FtklnlQBBzQdw7XxIHwAnEImPInI0WKJlW0LkmNfjJECYoLyUUE-CuWjgnwi8mY5Y9IU4_jH2BOU2nIcltEOF6rptWqtUglhE-zP1WG5YdZjCFQ7J-EdZS5dkkbk1ULmCswOYym6dNVNrZC54eFZlkXkaaMDy0ctdCgiYk071t5l_U5ZDENpbw7sT7LO8_-e-YJs4xrEIW62S7Zm0xv3EmDTzOyF44a9YBN_APh1G1U |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Behavioral+and+Psychiatric+Symptoms+of+Dementia+and+Rate+of+Decline+in+Alzheimer%E2%80%99s+Disease&rft.jtitle=Frontiers+in+pharmacology&rft.au=Gottesman%2C+Reena+T.&rft.au=Stern%2C+Yaakov&rft.date=2019-09-24&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=10&rft_id=info:doi/10.3389%2Ffphar.2019.01062&rft_id=info%3Apmid%2F31616296&rft.externalDocID=PMC6768941 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |